This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Shicheng Guo
shihcheng.bsky.social
did:plc:6vo56vqh2erei7xqs2t5nqbu
Antibody MEDI6570 targets LOX-1 to reduce inflammation post-MI. In a randomized trial, it curbed inflammation in patients with hsCRP ≥1 mg/L. PMID:40999229, Nat Med 2025, @NatureMedicine https://doi.org/10.1038/s41591-025-03951-w #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
2025-10-12T06:10:05.287Z